F
Fergus Shanahan
Researcher at National University of Ireland
Publications - 727
Citations - 59181
Fergus Shanahan is an academic researcher from National University of Ireland. The author has contributed to research in topics: Inflammatory bowel disease & Gut flora. The author has an hindex of 117, co-authored 705 publications receiving 51963 citations. Previous affiliations of Fergus Shanahan include Imperial College London & Mater Misericordiae Hospital.
Papers
More filters
Journal ArticleDOI
Selection of Symptomatic Patients With Crohn's Disease for Abdominopelvic Computed Tomography: Role of Serum C-Reactive Protein
Alan N. Desmond,Kevin O'Regan,Neera Malik,Sebastian McWilliams,Siobhan B. O’Neill,Eamonn Martin Quigley,Fergus Shanahan,Michael M. Maher +7 more
TL;DR: Symptomatic patients with Crohn's disease and normal serum CRP are unlikely to have evidence of abscess, fistulating disease, or large bowel luminal disease detected on abdominopelvic CT, however, abdominal CT may demonstrate evidence of clinically significant non-penetrating CD or complications, including perforation and acute obstruction, regardless of serumCRP concentration.
Journal ArticleDOI
Systemic Inflammatory Markers and Disease Severity in Chronic Obstructive Pulmonary Disease—The Effect of Acute Exercise and Pulmonary Rehabilitation
Amani I. El Gammal,Rob O'Farrell,Liam O'Mahony,Fergus Shanahan,Kieran Killian,Terence M. O'Connor +5 more
TL;DR: Reduced lung function is associated with increased levels of systemic inflammatory markers and acute exercise can further increase this inflammatory response, however pulmonary rehabilitation is unlikely to exacerbate systemic inflammation in COPD.
Book ChapterDOI
Understanding symptoms and signs in inflammatory bowel disease
TL;DR: UC shows greater variability between patients in clinical features, and as the disease evolves involving different parts of the gastrointestinal tract, the clinical features in any one patient may also change through time.
Journal ArticleDOI
Oral immune tolerance to tumor specific antigens may confer growth advantage to esophageal and gastric cancers
TL;DR: These experiments demonstrate antigen specific oral immune tolerance for tumors, which is reflected in a faster growth rate and impaired delayed type hypersensitivity response.